Chapter
The Benefits of Psilocybin on Chronic Depression
35:15 - 47:58 (12:42)
Tim Ferriss speaks about his donation of over $100,000 to psychedelic research for treating chronic depression with psilocybin administration. The study will evaluate the beneficial effects and persistence of psilocybin in treating chronic depression that is unresponsive to other treatments, with the use of fMRI and other imaging tools to measure and determine its effects.
Clips
Tim Ferriss talks about his support for psychedelic research in top universities with a focus on investigating the effects of psilocybin on treatment-resistant depression using imaging tools to measure its effectiveness.
35:15 - 38:27 (03:11)
Summary
Tim Ferriss talks about his support for psychedelic research in top universities with a focus on investigating the effects of psilocybin on treatment-resistant depression using imaging tools to measure its effectiveness.
ChapterThe Benefits of Psilocybin on Chronic Depression
Episode#171: The Random Show - New Favorite Books, Memory Training, and Bets On VR
PodcastThe Tim Ferriss Show
Researching psilocybin is challenging due to the difficulty of obtaining approvals for human trials and the high cost of acquiring the compound.
38:27 - 43:54 (05:27)
Summary
Researching psilocybin is challenging due to the difficulty of obtaining approvals for human trials and the high cost of acquiring the compound. Synthetic psilocybin is typically used in trials, rather than mushrooms.
ChapterThe Benefits of Psilocybin on Chronic Depression
Episode#171: The Random Show - New Favorite Books, Memory Training, and Bets On VR
PodcastThe Tim Ferriss Show
Psychedelics like psilocybin are being researched in their potential to alleviate anxiety and depression in terminal cancer patients and veterans with PTSD.
43:54 - 47:58 (04:03)
Summary
Psychedelics like psilocybin are being researched in their potential to alleviate anxiety and depression in terminal cancer patients and veterans with PTSD. The early stages of research are being carefully chosen and build upon successful cannabinoid treatment in cancer patients.